- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05507320
Neural Circuits for Action Perception
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subjects will participate in a task where they have to either
- Perform a movement
- Observe an actor performing a movement There are three types of actions including different kinematics and grip types The goal is to compare the neural circuits activated by action execution versus action observation.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Gabriel Kreiman, PhD
- Phone Number: 6179192530
- Email: gabriel.kreiman@tch.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Boston Children's Hospital
-
Contact:
- Dominguez Robleinscky
- Phone Number: 617-919-2530
- Email: domingues.robleinscky@childrens.harvard.edu
-
Contact:
- Gabriel Kreiman
- Phone Number: 6179192242
- Email: gabriel.kreiman@tch.harvard.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with pharmacologically intractable epilepsy
Exclusion Criteria:
- Any situation that may put the patient at risk
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Selectivity for kinematics and movement type in neurophysiological responses
Time Frame: Through study completion, an average of 2 years.
|
Measure intracranial field potentials (in microvolts) in the gamma frequency band through neurophysiological responses comparing neural responses during action perception versus execution. We will assess selectivity for kinematics for each movement type |
Through study completion, an average of 2 years.
|
Evoked responses by action execution
Time Frame: Through study completion, an average of 2 years.
|
Measure intracranial field potentials (in microvolts) in the gamma frequency band through neurophysiological responses comparing neural responses during action perception versus execution. We will quantify responses evoked by action execution |
Through study completion, an average of 2 years.
|
Evoked responses by action observation
Time Frame: Through study completion, an average of 2 years.
|
Measure intracranial field potentials (in microvolts) in the gamma frequency band through neurophysiological responses comparing neural responses during action perception versus execution. We will quantify responses evoked by action observation |
Through study completion, an average of 2 years.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Gabriel Kreiman, PhD, CHB
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB_P0405065R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsNot yet recruitingEpilepsy, Drug ResistantChina
Clinical Trials on Mechanisms of action perception and execution
-
CNR Institute of Neuroscience, ParmaHumanitas Hospital, ItalyRecruiting
-
Universidad Politecnica de MadridCompleted
-
Federal University of Health Science of Porto AlegreNot yet recruiting
-
IRCCS San RaffaeleCompleted
-
Russell L. WoodsResearch to Prevent Blindness / Lions Club International FoundationNot yet recruitingCentral Visual Impairment
-
Ain Shams UniversityUnknownBreast Cancer | Clinical TrialsEgypt
-
University Hospital, CaenCompleted
-
National Taiwan University HospitalMinistry of Health and Welfare, TaiwanEnrolling by invitation
-
University Hospital, Basel, SwitzerlandCompleted
-
Columbia UniversityNovartisRecruitingCarcinoma, Renal CellUnited States